|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000257017 |
Summary for HP |
Gene summary |
| Gene information | Ensembl ID | ENSG00000257017 | Gene symbol | HP |
| Gene name | haptoglobin | |
| HGNC | 5141 | |
| Entrez ID | 3240 | |
| Gene type | protein_coding | |
| Synonyms | HP| | |
| UniProtAcc | P00738 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| ENSG00000257017 | HP | DB14533 | Zinc chloride | SmallMoleculeDrug |
| ENSG00000257017 | HP | DB14548 | Zinc sulfate, unspecified form | SmallMoleculeDrug |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for HP |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| HP | 9.16e+01 | -3.21e+00 | 7.21e-01 | -4.45e+00 | 8.72e-06 | 3.29e-04 | BRCA |
| HP | 1.69e+03 | 1.05e+00 | 2.88e-01 | 3.65e+00 | 2.59e-04 | 2.42e-03 | KIRC |
| HP | 1.14e+02 | 2.50e+00 | 4.04e-01 | 6.19e+00 | 6.03e-10 | 3.59e-08 | KIRP |
| HP | 1.44e+01 | 2.27e+00 | 4.03e-01 | 5.62e+00 | 1.93e-08 | 1.28e-05 | READ |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| HP | 7.41e+01 | 3.33e+00 | 5.24e-01 | 6.36e+00 | 2.01e-10 | 2.47e-09 | THCA |
| HP | 1.75e+03 | -1.46e+00 | 4.03e-01 | -3.62e+00 | 2.93e-04 | 4.75e-04 | LUSC |
| HP | 1.33e+02 | 2.18e+00 | 6.84e-01 | 3.18e+00 | 1.47e-03 | 3.01e-03 | KIRP |
| HP | 4.77e+05 | -4.94e+00 | 1.14e+00 | -4.33e+00 | 1.49e-05 | 8.02e-05 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for HP |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for HP |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| HNSC | cg06172871 | chr16:72054345 | CGI:chr16:72093230-72093442 | promoter | 5.95e-01 | 7.16e-01 | -2.23e+00 | 2.56e-02 | 2.84e-02 | -1.20e-01 |
| BLCA | cg06172871 | chr16:72054345 | CGI:chr16:72093230-72093442 | promoter | 5.58e-01 | 7.65e-01 | -3.41e+00 | 6.48e-04 | 1.62e-03 | -2.07e-01 |
| LIHC | cg06172871 | chr16:72054345 | CGI:chr16:72093230-72093442 | promoter | 2.86e-01 | 3.95e-01 | -3.95e+00 | 7.74e-05 | 1.65e-04 | -1.09e-01 |
| CHOL | cg06172871 | chr16:72054345 | CGI:chr16:72093230-72093442 | promoter | 7.00e-01 | 3.68e-01 | 2.65e+00 | 7.96e-03 | 1.92e-02 | 3.33e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg06172871 | chr16:72054345 | CGI:chr16:72093230-72093442 | promoter | 7.94e-01 | 6.67e-01 | 1.07e+01 | 7.94e-27 | 8.08e-26 | 1.27e-01 |
Top |
Exon skipping events with PSI in TCGA for HP |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for HP |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for HP |
TFs related to HP.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
HP related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for HP |
RBPs related to ES in HP.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
HP related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs1051432 | chr16:74873752:G:C | - | -0.255117789826055 | 4.54737799600909e-07 | KIRP | Female-baised eQTL |
| rs56397326 | chr16:78961593:G:A | - | 0.255475227065635 | 4.59696689903538e-07 | KIRP | Female-baised eQTL |
| rs72808748 | chr16:78961970:T:C | - | 0.255556393657674 | 4.63049351390009e-07 | KIRP | Female-baised eQTL |
| rs4889412 | chr16:81853030:T:C | - | 0.255415995753315 | 4.63049351390009e-07 | KIRP | Female-baised eQTL |
| rs28580080 | chr16:81861653:C:T | - | 0.22880365466581 | 9.99301584779514e-06 | KIRP | Female-baised eQTL |
| rs12148948 | chr16:78951700:C:T | - | 0.206886482218482 | 8.6775396249077e-05 | KIRP | Female-baised eQTL |
| rs12448599 | chr16:64345006:G:A | - | 0.151982718773101 | 0.00762707534027026 | KIRP | Female-baised eQTL |
| rs12448650 | chr16:64345172:G:A | - | 0.151982718773101 | 0.00762707534027026 | KIRP | Female-baised eQTL |
| rs62039826 | chr16:64348152:A:T | - | 0.151982718773101 | 0.00762707534027026 | KIRP | Female-baised eQTL |
| rs16967367 | chr16:64348913:A:G | - | 0.151982718773101 | 0.00762707534027026 | KIRP | Female-baised eQTL |
| rs62039841 | chr16:64352175:A:G | - | 0.151982718773101 | 0.00762707534027026 | KIRP | Female-baised eQTL |
| rs62039842 | chr16:64352547:T:G | - | 0.151982718773101 | 0.00762707534027026 | KIRP | Female-baised eQTL |
| rs16967378 | chr16:64354524:A:G | - | 0.151982718773101 | 0.00762707534027026 | KIRP | Female-baised eQTL |
| rs62039852 | chr16:64370652:A:G | - | 0.151982718773101 | 0.00762707534027026 | KIRP | Female-baised eQTL |
| rs62039824 | chr16:64343733:G:A | - | 0.152121725371933 | 0.00763830232571057 | KIRP | Female-baised eQTL |
| rs62039708 | chr16:79315970:C:A | - | 0.147444765256133 | 0.00918929861171827 | KIRP | Female-baised eQTL |
| rs72794776 | chr16:74835024:G:A | - | 0.138327267227955 | 0.017045322902074 | KIRP | Female-baised eQTL |
| rs79955504 | chr16:74835528:G:C | - | 0.138327267227955 | 0.017045322902074 | KIRP | Female-baised eQTL |
| rs16967364 | chr16:64348417:G:T | - | 0.135084327667546 | 0.0248166198797554 | KIRP | Female-baised eQTL |
| rs16967379 | chr16:64354733:T:C | - | 0.135084327667546 | 0.0248166198797554 | KIRP | Female-baised eQTL |
| rs16967421 | chr16:64367581:T:C | - | 0.135084327667546 | 0.0248166198797554 | KIRP | Female-baised eQTL |
| rs16967425 | chr16:64372256:T:C | - | 0.135242404923926 | 0.024847037397875 | KIRP | Female-baised eQTL |
| rs12448632 | chr16:64345279:C:T | - | 0.135242351418372 | 0.024847037397875 | KIRP | Female-baised eQTL |
| rs62039829 | chr16:64350671:A:G | - | 0.135242351418372 | 0.024847037397875 | KIRP | Female-baised eQTL |
| rs62039830 | chr16:64350956:A:G | - | 0.135242351418372 | 0.024847037397875 | KIRP | Female-baised eQTL |
| rs62039843 | chr16:64352767:A:G | - | 0.135242351418372 | 0.024847037397875 | KIRP | Female-baised eQTL |
| rs12448245 | chr16:64360316:G:A | - | 0.135242351418372 | 0.024847037397875 | KIRP | Female-baised eQTL |
| rs62039825 | chr16:64343766:C:T | - | 0.135405679259839 | 0.0248848303147272 | KIRP | Female-baised eQTL |
| rs35695084 | chr16:78155046:C:T | - | 0.135230202604909 | 0.024890854334265 | KIRP | Female-baised eQTL |
| rs16954399 | chr16:80986788:T:C | - | 0.130513036244248 | 0.0290772530328911 | KIRP | Female-baised eQTL |
| rs62046499 | chr16:77487439:G:T | - | 0.13049913640833 | 0.0290876847861033 | KIRP | Female-baised eQTL |
| rs79667821 | chr16:81835255:T:C | - | 0.249923255046874 | 0.0333123999768503 | KIRP | Female-baised eQTL |
| rs74383491 | chr16:81835844:C:T | - | 0.249923255046874 | 0.0333123999768503 | KIRP | Female-baised eQTL |
| rs117353991 | chr16:81836556:C:T | - | 0.249923255046874 | 0.0333123999768503 | KIRP | Female-baised eQTL |
| rs73590821 | chr16:81838819:T:C | - | 0.249923255046874 | 0.0333123999768503 | KIRP | Female-baised eQTL |
| rs58899768 | chr16:81839476:A:T | - | 0.249923255046874 | 0.0333123999768503 | KIRP | Female-baised eQTL |
| rs34767902 | chr16:78146246:G:C | - | 0.1285040346568 | 0.0390272393022146 | KIRP | Female-baised eQTL |
| rs9940258 | chr16:65878665:T:C | - | 0.1236838006337 | 0.0446995705698561 | KIRP | Female-baised eQTL |
| rs59313288 | chr16:79324388:T:C | - | 0.123771105405102 | 0.0448599592067761 | KIRP | Female-baised eQTL |
| rs75666408 | chr16:79325184:T:C | - | 0.123771105405102 | 0.0448599592067761 | KIRP | Female-baised eQTL |
| rs16970719 | chr16:72218205:G:C | - | 0.120532358823448 | 0.0497981965318341 | KIRP | Female-baised eQTL |
| rs35223533 | chr16:72218645:A:T | - | 0.120532358823448 | 0.0497981965318341 | KIRP | Female-baised eQTL |
| rs7185174 | chr16:65782241:T:C | - | -0.249449324081663 | 0.0362861985117188 | LIHC | Female-baised eQTL |
| rs7184129 | chr16:65782242:G:A | - | -0.249449324081663 | 0.0362861985117188 | LIHC | Female-baised eQTL |
| rs35199366 | chr16:78335231:A:G | - | 0.116321893275159 | 1.54636032993163e-06 | KIRC | Female-baised eQTL |
| rs62040105 | chr16:79034594:G:A | - | 0.085107566550913 | 0.000572487880895546 | KIRC | Female-baised eQTL |
| rs10500471 | chr16:63059030:T:G | - | 0.0851812549358026 | 0.000576865602569908 | KIRC | Female-baised eQTL |
| rs62045347 | chr16:63331774:G:C | - | 0.082071552985878 | 0.000935545167633954 | KIRC | Female-baised eQTL |
| rs4949113 | chr16:63203814:G:A | - | 0.0791578580908789 | 0.00150847688284686 | KIRC | Female-baised eQTL |
| rs62045266 | chr16:63287385:C:T | - | 0.0741513146760957 | 0.00339308885561048 | KIRC | Female-baised eQTL |
| rs4534868 | chr16:63269119:A:C | - | 0.0723209837972696 | 0.0042573522318971 | KIRC | Female-baised eQTL |
| rs17549676 | chr16:63310828:G:A | - | 0.0685767590821018 | 0.00734600126798577 | KIRC | Female-baised eQTL |
| rs13353174 | chr16:78139601:C:T | - | 0.060033235447885 | 0.021584879687192 | KIRC | Female-baised eQTL |
| rs12933949 | chr16:78330629:T:A | - | 0.0573898591614295 | 0.0360969499820322 | KIRC | Female-baised eQTL |
| rs77754442 | chr16:78165021:G:C | - | 0.0563925808713352 | 0.0380661351300475 | KIRC | Female-baised eQTL |
| rs197171 | chr16:63058165:C:A | - | -0.0568432487897338 | 0.0409310590270779 | KIRC | Female-baised eQTL |
| rs1605961 | chr16:63064303:C:G | - | -0.0568432487897338 | 0.0409310590270779 | KIRC | Female-baised eQTL |
| rs8051889 | chr16:63069679:C:T | - | -0.0568432487897338 | 0.0409310590270779 | KIRC | Female-baised eQTL |
| rs11150048 | chr16:78169797:G:C | - | 0.0551159888142999 | 0.0449636086595889 | KIRC | Female-baised eQTL |
| rs198003 | chr16:63079985:T:C | - | -0.0555303706222479 | 0.0479537891791286 | KIRC | Female-baised eQTL |
| rs145872064 | chr16:68910864:A:G | - | 0.0651860300407369 | 0.0399383463811733 | LUAD | Female-baised eQTL |
| rs201729847 | chr16:68911416:T:C | - | 0.0651860300407369 | 0.0399383463811733 | LUAD | Female-baised eQTL |
| rs16958470 | chr16:68921651:T:C | - | 0.0651860300407369 | 0.0399383463811733 | LUAD | Female-baised eQTL |
| rs10500546 | chr16:68922722:A:G | - | 0.0651860300407369 | 0.0399383463811733 | LUAD | Female-baised eQTL |
| rs28645609 | chr16:68925241:T:C | - | 0.0434765378897375 | 0.0437041946089033 | LUAD | Female-baised eQTL |
| rs16958486 | chr16:68926861:C:G | - | 0.0606045821139603 | 0.0456263565264599 | LUAD | Female-baised eQTL |
| rs116990888 | chr16:68931916:A:G | - | 0.043106163155741 | 0.0461976222177539 | LUAD | Female-baised eQTL |
| rs78235713 | chr16:68932503:A:G | - | 0.043106163155741 | 0.0461976222177539 | LUAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs17706673 | chr16:78516098:A:G | - | 0.181640205749161 | 0.00774095449347422 | GBM | Male-baised eQTL |
| rs12918302 | chr16:78884631:G:C | - | 0.157897874202844 | 0.0367834515247685 | GBM | Male-baised eQTL |
| rs7201040 | chr16:75691042:G:A | - | 0.235725384196459 | 0.0378236429012381 | GBM | Male-baised eQTL |
| rs117671439 | chr16:71364220:T:A | - | 0.0510369643855459 | 0.0485926349309624 | KIRP | Male-baised eQTL |
| rs11075766 | chr16:70529368:A:G | - | 0.0472405376055576 | 0.0008470146253905 | KIRC | Male-baised eQTL |
| rs4888340 | chr16:75089596:C:T | - | -0.0411966887660526 | 0.00308480182605879 | KIRC | Male-baised eQTL |
| rs16968359 | chr16:65038680:A:G | - | 0.0344888529822031 | 0.0244446482635725 | KIRC | Male-baised eQTL |
| rs7198314 | chr16:65009069:G:A | - | 0.0336341955332827 | 0.0285725925815256 | KIRC | Male-baised eQTL |
| rs8048429 | chr16:65011016:T:G | - | 0.0336341955332827 | 0.0285725925815256 | KIRC | Male-baised eQTL |
| rs74026226 | chr16:65020030:A:C | - | 0.0336347613613854 | 0.0287760197785773 | KIRC | Male-baised eQTL |
| rs74026228 | chr16:65023824:A:C | - | 0.0336347613613854 | 0.0287760197785773 | KIRC | Male-baised eQTL |
| rs7192855 | chr16:65024488:A:G | - | 0.0336347613613854 | 0.0287760197785773 | KIRC | Male-baised eQTL |
| rs74026230 | chr16:65030232:A:G | - | 0.0336347613613854 | 0.0287760197785773 | KIRC | Male-baised eQTL |
| rs16968351 | chr16:65032803:A:G | - | 0.0331987621983245 | 0.0315726271868461 | KIRC | Male-baised eQTL |
| rs1559309 | chr16:66032808:A:G | - | -0.0384171759094312 | 0.0432341345759662 | KIRC | Male-baised eQTL |
| rs1564437 | chr16:73698059:A:T | - | 0.0362488283568299 | 0.0435382506357246 | KIRC | Male-baised eQTL |
| rs9937938 | chr16:66026328:T:C | - | -0.038398105924333 | 0.0436521187161 | KIRC | Male-baised eQTL |
| rs7201152 | chr16:66033135:G:T | - | -0.0376795833880271 | 0.0484063709549118 | KIRC | Male-baised eQTL |
| rs1111220 | chr16:66033739:C:T | - | -0.0376660395782923 | 0.0487912854984665 | KIRC | Male-baised eQTL |
| rs79017333 | chr16:73693551:C:T | - | 0.0355446225339746 | 0.0495426747332702 | KIRC | Male-baised eQTL |
| rs4889027 | chr16:79779333:C:T | - | -0.0598623990995487 | 0.0207633133505816 | LUAD | Male-baised eQTL |
| rs4310864 | chr16:79781121:C:G | - | -0.0598958309134737 | 0.0207769310812415 | LUAD | Male-baised eQTL |
| rs7191710 | chr16:79783582:A:T | - | -0.0598958309134737 | 0.0207769310812415 | LUAD | Male-baised eQTL |
| rs2911310 | chr16:62604325:G:A | - | 0.041438098288298 | 0.025609953157889 | LUAD | Male-baised eQTL |
| rs2911313 | chr16:62605195:T:C | - | 0.041438098288298 | 0.025609953157889 | LUAD | Male-baised eQTL |
| rs2911305 | chr16:62599203:T:C | - | 0.0393625012912609 | 0.0362104535803337 | LUAD | Male-baised eQTL |
| rs2911304 | chr16:62598818:A:G | - | 0.0389765278450481 | 0.0391664770983586 | LUAD | Male-baised eQTL |
| rs62040159 | chr16:79971494:G:T | - | 0.0557926481569532 | 0.0407799437160548 | LUAD | Male-baised eQTL |
| rs62042264 | chr16:79973279:C:T | - | 0.0557926481569532 | 0.0407799437160548 | LUAD | Male-baised eQTL |
| rs4474699 | chr16:79975408:T:C | - | 0.0557530160935985 | 0.0412738306059528 | LUAD | Male-baised eQTL |
| rs4243197 | chr16:79977567:C:G | - | 0.0557530160935985 | 0.0412738306059528 | LUAD | Male-baised eQTL |
| rs62042288 | chr16:79977846:C:A | - | 0.0557530160935985 | 0.0412738306059528 | LUAD | Male-baised eQTL |
| rs16951873 | chr16:79974291:C:T | - | 0.0557378374960953 | 0.0415554816368034 | LUAD | Male-baised eQTL |
| rs77097848 | chr16:79974680:C:T | - | 0.0557378374960953 | 0.0415554816368034 | LUAD | Male-baised eQTL |
| rs62042286 | chr16:79975072:C:T | - | 0.0557378374960953 | 0.0415554816368034 | LUAD | Male-baised eQTL |
| rs4473201 | chr16:79976394:T:G | - | 0.0557378374960953 | 0.0415554816368034 | LUAD | Male-baised eQTL |
| rs62042287 | chr16:79976905:A:C | - | 0.0557378374960953 | 0.0415554816368034 | LUAD | Male-baised eQTL |
| rs62040152 | chr16:79965670:A:G | - | 0.0535352582752022 | 0.0480319372177575 | LUAD | Male-baised eQTL |
| rs62042291 | chr16:79978506:C:A | - | 0.0543896677639813 | 0.048594211443111 | LUAD | Male-baised eQTL |
| rs62042292 | chr16:79979124:G:A | - | 0.0543744240245802 | 0.0488799356073888 | LUAD | Male-baised eQTL |
| rs8044242 | chr16:79979690:A:G | - | 0.0543522734701546 | 0.0490968882336906 | LUAD | Male-baised eQTL |
| rs4243195 | chr16:79969579:T:C | - | 0.0543355824538015 | 0.049220399450801 | LUAD | Male-baised eQTL |
| rs4600479 | chr16:79971181:G:A | - | 0.0543197371709341 | 0.0493782242834374 | LUAD | Male-baised eQTL |
| rs62042296 | chr16:79982117:C:T | - | 0.0543305341427911 | 0.0496524300666709 | LUAD | Male-baised eQTL |
| rs62042260 | chr16:79971603:C:T | - | 0.0543048153947723 | 0.0497225329073932 | LUAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Gene ID: ENSG00000257017 | |
| CpG Site: cg06172871 | |
| Position to Gene: promoter | |
| Male Effect: - | |
| Female Effect: -0.499976616008416 |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg06172871 | chr16:72054345 | promoter | -0.499976616008416 | 5.71490448302397e-190 | -0.99999876696196 | 7.78040954925657e-201 | KIRP |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of HP |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000257017 | HP | C0001723 | Affective Disorders, Psychotic | 1 | PSYGENET |
| ENSG00000257017 | HP | C0002871 | Anemia | 1 | CTD_human |
| ENSG00000257017 | HP | C0002895 | Anemia, Sickle Cell | 1 | CTD_human |
| ENSG00000257017 | HP | C0003864 | Arthritis | 1 | CTD_human |
| ENSG00000257017 | HP | C0004153 | Atherosclerosis | 1 | CTD_human |
| ENSG00000257017 | HP | C0004364 | Autoimmune Diseases | 1 | CTD_human |
| ENSG00000257017 | HP | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
| ENSG00000257017 | HP | C0007222 | Cardiovascular Diseases | 1 | CTD_human |
| ENSG00000257017 | HP | C0011570 | Mental Depression | 3 | PSYGENET |
| ENSG00000257017 | HP | C0011581 | Depressive disorder | 3 | PSYGENET |
| ENSG00000257017 | HP | C0011854 | Diabetes Mellitus, Insulin-Dependent | 1 | CTD_human |
| ENSG00000257017 | HP | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human |
| ENSG00000257017 | HP | C0011875 | Diabetic Angiopathies | 1 | CTD_human |
| ENSG00000257017 | HP | C0013221 | Drug toxicity | 1 | CTD_human |
| ENSG00000257017 | HP | C0016479 | Food Poisoning | 1 | CTD_human |
| ENSG00000257017 | HP | C0017416 | Genital Neoplasms, Female | 1 | CTD_human |
| ENSG00000257017 | HP | C0018995 | Hemochromatosis | 1 | CTD_human |
| ENSG00000257017 | HP | C0019054 | Hemolysis (disorder) | 1 | CTD_human |
| ENSG00000257017 | HP | C0019163 | Hepatitis B | 1 | CTD_human |
| ENSG00000257017 | HP | C0019693 | HIV Infections | 1 | CTD_human |
| ENSG00000257017 | HP | C0020517 | Hypersensitivity | 1 | CTD_human |
| ENSG00000257017 | HP | C0020538 | Hypertensive disease | 1 | CTD_human |
| ENSG00000257017 | HP | C0022660 | Kidney Failure, Acute | 1 | CTD_human |
| ENSG00000257017 | HP | C0023418 | leukemia | 1 | CTD_human |
| ENSG00000257017 | HP | C0024530 | Malaria | 2 | CTD_human |
| ENSG00000257017 | HP | C0025945 | Microangiopathy, Diabetic | 1 | CTD_human |
| ENSG00000257017 | HP | C0027051 | Myocardial Infarction | 3 | CTD_human |
| ENSG00000257017 | HP | C0035305 | Retinal Detachment | 1 | CTD_human |
| ENSG00000257017 | HP | C0036341 | Schizophrenia | 1 | CTD_human |
| ENSG00000257017 | HP | C0041296 | Tuberculosis | 1 | CTD_human |
| ENSG00000257017 | HP | C0041696 | Unipolar Depression | 4 | PSYGENET |
| ENSG00000257017 | HP | C0041755 | Adverse reaction to drug | 1 | CTD_human |
| ENSG00000257017 | HP | C0085397 | Pasteurellaceae Infections | 1 | CTD_human |
| ENSG00000257017 | HP | C0162323 | Polyarthritis | 1 | CTD_human |
| ENSG00000257017 | HP | C0205734 | Diabetes, Autoimmune | 1 | CTD_human |
| ENSG00000257017 | HP | C0235574 | Intravascular hemolysis | 1 | CTD_human |
| ENSG00000257017 | HP | C0242339 | Dyslipidemias | 1 | CTD_human |
| ENSG00000257017 | HP | C0312854 | Extravascular Hemolysis | 1 | CTD_human |
| ENSG00000257017 | HP | C0339546 | Retinal Pigment Epithelial Detachment | 1 | CTD_human |
| ENSG00000257017 | HP | C0341934 | Transient hypertension of pregnancy | 1 | CTD_human |
| ENSG00000257017 | HP | C0342257 | Complications of Diabetes Mellitus | 1 | CTD_human |
| ENSG00000257017 | HP | C0342302 | Brittle diabetes | 1 | CTD_human |
| ENSG00000257017 | HP | C0392514 | Hereditary hemochromatosis | 1 | CTD_human |
| ENSG00000257017 | HP | C0524909 | Hepatitis B, Chronic | 1 | CTD_human |
| ENSG00000257017 | HP | C0524910 | Hepatitis C, Chronic | 1 | CTD_human |
| ENSG00000257017 | HP | C0525045 | Mood Disorders | 2 | PSYGENET |
| ENSG00000257017 | HP | C0598784 | Dyslipoproteinemias | 1 | CTD_human |
| ENSG00000257017 | HP | C0678222 | Breast Carcinoma | 1 | CTD_human |
| ENSG00000257017 | HP | C0679360 | Foodborne Disease | 1 | CTD_human |
| ENSG00000257017 | HP | C0852036 | Pregnancy associated hypertension | 1 | CTD_human |
| ENSG00000257017 | HP | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
| ENSG00000257017 | HP | C1269683 | Major Depressive Disorder | 3 | PSYGENET |
| ENSG00000257017 | HP | C1458155 | Mammary Neoplasms | 1 | CTD_human |
| ENSG00000257017 | HP | C1527304 | Allergic Reaction | 1 | CTD_human |
| ENSG00000257017 | HP | C1563937 | Atherogenesis | 1 | CTD_human |
| ENSG00000257017 | HP | C1565662 | Acute Kidney Insufficiency | 1 | CTD_human |
| ENSG00000257017 | HP | C2609414 | Acute kidney injury | 1 | CTD_human |
| ENSG00000257017 | HP | C3837958 | Diabetes Mellitus, Ketosis-Prone | 1 | CTD_human |
| ENSG00000257017 | HP | C4505456 | HIV Coinfection | 1 | CTD_human |
| ENSG00000257017 | HP | C4554117 | Diabetes Mellitus, Sudden-Onset | 1 | CTD_human |
| ENSG00000257017 | HP | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |